Characterization of autoimmune eye disease in association with Down's Syndrome.


Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
03 May 2023
Historique:
medline: 19 5 2023
pubmed: 19 5 2023
entrez: 19 5 2023
Statut: epublish

Résumé

Background Autoimmunity and deficiency of the transcription factor autoimmune regulator protein (AIRE) are known associations with Down Syndrome (DS). Lack of AIRE abrogates thymic tolerance. The autoimmune eye disease associated with DS has not been characterized. We identified a series of subjects with DS (n = 8) and uveitis. In 3 consecutive subjects, we tested the hypothesis that autoimmunity to retinal antigens might be a contributing factor. Subjects/Methods: This was a multicentered, retrospective case series. De-identified clinical data of subjects with both DS and uveitis were collected via questionnaire by uveitis-trained ophthalmologists. Anti-retinal autoantibodies (AAbs) were detected using an Autoimmune Retinopathy Panel tested in the OHSU Ocular Immunology Laboratory. Results We characterized 8 subjects (mean age 29 [range, 19-37] years). The mean age of uveitis onset was 23.5 [range, 11-33] years. All 8 subjects had bilateral uveitis (p < 0.001 based on comparison to published university referral patterns), with anterior and intermediate uveitis found in 6 and 5 subjects respectively. Each of three subjects tested for anti-retinal AAbs was positive. Detected AAbs included anti-carbonic anhydrase II, anti-enolase, anti-arrestin, and anti-aldolase. Discussion A partial deficiency in the AIRE on chromosome 21 has been described in DS. The similarities in the uveitis presentations within this patient group, the known autoimmune disease predisposition in DS, the recognized association of DS and AIRE deficiency, the reported detection of anti-retinal antibodies in patients with DS in general, and the presence of anti-retinal AAbs in 3 subjects in our series supports a causal association between DS and autoimmune eye disease.

Identifiants

pubmed: 37205347
doi: 10.21203/rs.3.rs-2766021/v1
pmc: PMC10187437
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NEI NIH HHS
ID : P30 EY010572
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026572
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Diabetologia. 2006 Jun;49(6):1179-82
pubmed: 16575558
RMD Open. 2019 Jun 3;5(1):e000890
pubmed: 31245048
PLoS One. 2019 May 2;14(5):e0216320
pubmed: 31048931
Arch Dis Child. 2019 May;104(5):482-487
pubmed: 30472668
Clin Exp Immunol. 2012 Sep;169(3):238-43
pubmed: 22861363
Arch Dis Child. 2004 Nov;89(11):1014-7
pubmed: 15499053
Am J Ophthalmol. 1996 Jan;121(1):35-46
pubmed: 8554079
Clin Immunol. 2020 Jan;210:108317
pubmed: 31770612
Br J Ophthalmol. 2013 Apr;97(4):423-8
pubmed: 23376568
Arch Dis Child. 1997 Aug;77(2):186
pubmed: 9301372
J Ophthalmol. 2020 Feb 07;2020:9726261
pubmed: 32089873
Ophthalmology. 2004 Mar;111(3):491-500; discussion 500
pubmed: 15019324
Indian J Pediatr. 2014 Jun;81(6):560-7
pubmed: 24127006
Gut. 1997 Apr;40(4):492-6
pubmed: 9176077
Expert Rev Ophthalmol. 2020;15(2):111-118
pubmed: 32318114
J Clin Res Pediatr Endocrinol. 2013;5(2):116-20
pubmed: 23748065
Genet Med. 2017 Apr;19(4):439-447
pubmed: 27608174
Lancet. 2000 Jan 15;355(9199):165-9
pubmed: 10675114
Oncotarget. 2017 Sep 19;8(48):84489-84496
pubmed: 29137441
J Pediatr. 2013 Jul;163(1):237-42
pubmed: 23399451
J Immunol. 2014 Oct 15;193(8):3872-9
pubmed: 25217160
Cytokine. 2020 Mar;127:154938
pubmed: 31785499
Curr Eye Res. 2019 Aug;44(8):901-907
pubmed: 30961422
J Clin Endocrinol Metab. 2006 Aug;91(8):2843-50
pubmed: 16684821
Nature. 2023 Mar;615(7951):305-314
pubmed: 36813963
J Clin Endocrinol Metab. 2002 Dec;87(12):5495-8
pubmed: 12466343
Ophthalmology. 2004 Aug;111(8):1457-63
pubmed: 15288971
Front Pediatr. 2020 Feb 27;8:73
pubmed: 32175298
J Exp Med. 2006 Nov 27;203(12):2727-35
pubmed: 17116738

Auteurs

Classifications MeSH